Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression.
van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA.
Lancet Diabetes Endocrinol. 2020 Apr;8(4):325-336. doi: 10.1016/S2213-8587(19)30405-X. Epub 2020 Mar 2.
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, Owens DR, Thomas RL, Song S, Wong J, Chan JC, Luk AO, Penno G, Ji L, Mohan V, Amutha A, Romero-Aroca P, Gasevic D, Magliano DJ, Teede HJ, Chalmers J, Zoungas S.
Diabetologia. 2021 Feb;64(2):275-287. doi: 10.1007/s00125-020-05319-w. Epub 2020 Dec 14.
Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study.
Georgakis MK, Harshfield EL, Malik R, Franceschini N, Langenberg C, Wareham NJ, Markus HS, Dichgans M.
Neurology. 2021 Mar 30;96(13):e1732-e1742. doi: 10.1212/WNL.0000000000011555. Epub 2021 Jan 25.
Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
Xie W, Wang Y, Xiao S, Qiu L, Yu Y, Zhang Z.
BMJ. 2022 Sep 21;378:e070244. doi: 10.1136/bmj-2022-070244.
Canagliflozin and Stroke in Type 2 Diabetes Mellitus.
Zhou Z, Lindley RI, Rådholm K, Jenkins B, Watson J, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Shaw W, Oh R, Desai M, Matthews DR, Neal B.
Stroke. 2019 Feb;50(2):396-404. doi: 10.1161/STROKEAHA.118.023009.
Epidemiology of Cerebrovascular Disease Among Chinese Canadian Adults With Type 2 Diabetes.
Lam S, Chu JY.
Can J Diabetes. 2018 Feb;42(1):94-99. doi: 10.1016/j.jcjd.2017.02.001. Epub 2017 May 23.
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6.
Strain WD, Frenkel O, James MA, Leiter LA, Rasmussen S, Rothwell PM, Sejersten Ripa M, Truelsen TC, Husain M.
Stroke. 2022 Sep;53(9):2749-2757. doi: 10.1161/STROKEAHA.121.037775. Epub 2022 May 18.
Magnesium in disease prevention and overall health.
Volpe SL.
Adv Nutr. 2013 May 1;4(3):378S-83S. doi: 10.3945/an.112.003483.
Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
Sattar N, McMurray J, Borén J, Rawshani A, Omerovic E, Berg N, Halminen J, Skoglund K, Eliasson B, Gerstein HC, McGuire DK, Bhatt D, Rawshani A.
Circulation. 2023 Jun 20;147(25):1872-1886. doi: 10.1161/CIRCULATIONAHA.122.063374. Epub 2023 May 8.
Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline.
Chornenkyy Y, Wang WX, Wei A, Nelson PT.
Brain Pathol. 2019 Jan;29(1):3-17. doi: 10.1111/bpa.12655. Epub 2018 Oct 9.
